156 related articles for article (PubMed ID: 22329954)
21. Prevalence of multidrug and extensively drug-resistant tuberculosis in Beijing, China: a hospital-based retrospective study.
Wang D; Yang C; Kuang T; Lei H; Meng X; Tong A; He J; Jiang Y; Guo F; Dong M
Jpn J Infect Dis; 2010 Sep; 63(5):368-71. PubMed ID: 20859008
[TBL] [Abstract][Full Text] [Related]
22. Multidrug-resistant and extensively drug-resistant tuberculosis: a review.
Chan ED; Iseman MD
Curr Opin Infect Dis; 2008 Dec; 21(6):587-95. PubMed ID: 18978526
[TBL] [Abstract][Full Text] [Related]
23. Management of multidrug resistant tuberculosis.
Daley CL; Caminero JA
Semin Respir Crit Care Med; 2013 Feb; 34(1):44-59. PubMed ID: 23460005
[TBL] [Abstract][Full Text] [Related]
24. Multidrug and extensively drug-resistant TB (M/XDR-TB): problems and solutions.
Prasad R
Indian J Tuberc; 2010 Oct; 57(4):180-91. PubMed ID: 21141336
[TBL] [Abstract][Full Text] [Related]
25. Multidrug-resistant and extensively drug-resistant tuberculosis in the West. Europe and United States: epidemiology, surveillance, and control.
Migliori GB; D'Arcy Richardson M; Sotgiu G; Lange C
Clin Chest Med; 2009 Dec; 30(4):637-65, vii. PubMed ID: 19925959
[TBL] [Abstract][Full Text] [Related]
26. HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients--a trend.
Rajasekaran S; Chandrasekar C; Mahilmaran A; Kanakaraj K; Karthikeyan DS; Suriakumar J
J Indian Med Assoc; 2009 May; 107(5):281-2, 284-6. PubMed ID: 19886382
[TBL] [Abstract][Full Text] [Related]
27. [Drug resistant tuberculosis].
Zwolska Z; Augustynowicz-Kopeć E
Pol Merkur Lekarski; 2011 May; 30(179):362-6. PubMed ID: 21675144
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of drug resistance in Mycobacterium tuberculosis.
Zhang Y; Yew WW
Int J Tuberc Lung Dis; 2009 Nov; 13(11):1320-30. PubMed ID: 19861002
[TBL] [Abstract][Full Text] [Related]
29. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
30. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
31. Treatment of extensively drug-resistant tuberculosis and role of the pharmacist.
Mitrzyk BM
Pharmacotherapy; 2008 Oct; 28(10):1243-54. PubMed ID: 18823220
[TBL] [Abstract][Full Text] [Related]
32. Extensively drug resistant tuberculosis (XDR-TB) in Chest Disease Institute, 1997-2005.
Chuchottaworn C
J Med Assoc Thai; 2010 Jan; 93(1):34-7. PubMed ID: 20196408
[TBL] [Abstract][Full Text] [Related]
33. Household contact investigation of multidrug-resistant and extensively drug-resistant tuberculosis in a high HIV prevalence setting.
Vella V; Racalbuto V; Guerra R; Marra C; Moll A; Mhlanga Z; Maluleke M; Mhlope H; Margot B; Friedland G; Shah NS; Gandhi NR
Int J Tuberc Lung Dis; 2011 Sep; 15(9):1170-5, i. PubMed ID: 21943840
[TBL] [Abstract][Full Text] [Related]
34. Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases.
Migliori GB; Lange C; Centis R; Sotgiu G; Mütterlein R; Hoffmann H; Kliiman K; De Iaco G; Lauria FN; Richardson MD; Spanevello A; Cirillo DM;
Eur Respir J; 2008 Jun; 31(6):1155-9. PubMed ID: 18515555
[TBL] [Abstract][Full Text] [Related]
35. Impact of extensively drug-resistant tuberculosis on treatment outcome of multidrug-resistant tuberculosis patients with standardized regimen: report from Iran.
Tabarsi P; Chitsaz E; Baghaei P; Shamaei M; Farnia P; Marjani M; Kazempour M; Amiri M; Mansouri D; Masjedi MR; Velayati AA; Caminero JA
Microb Drug Resist; 2010 Mar; 16(1):81-6. PubMed ID: 20192820
[TBL] [Abstract][Full Text] [Related]
36. Drug susceptibility patterns of Mycobacterium tuberculosis and clinical outcomes of drug-resistant tuberculosis at Srinagarind Hospital, a tertiary care center in northeastern Thailand.
Reechaipichitkul W; Tubtim S; Chaimanee P
Southeast Asian J Trop Med Public Health; 2011 Sep; 42(5):1154-62. PubMed ID: 22299441
[TBL] [Abstract][Full Text] [Related]
37. Extensively drug-resistant (XDR) tuberculosis: an old and new threat.
Fattorini L; Migliori GB; Cassone A
Ann Ist Super Sanita; 2007; 43(4):317-9. PubMed ID: 18209265
[TBL] [Abstract][Full Text] [Related]
38. Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework.
Pablos-Mendez A; Gowda DK; Frieden TR
Bull World Health Organ; 2002; 80(6):489-95; discussion 495-500. PubMed ID: 12132008
[TBL] [Abstract][Full Text] [Related]
39. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs--worldwide, 2000-2004.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2006 Mar; 55(11):301-5. PubMed ID: 16557213
[TBL] [Abstract][Full Text] [Related]
40. [Factors related to the occurrence of multi- (extensively-) drug resistant tuberculosis (M/XDR-TB) in our hospital].
Okumura M; Yoshiyama T; Ogata H; Morimoto K; Kokuto H; Kurashima A; Kudoh S
Kekkaku; 2011 Nov; 86(11):863-8. PubMed ID: 22250465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]